Gland Pharma Ltd

Gland Pharma Annual General Meeting

Gland Pharma's shareholders approved the appointment of Xingli Wang as Non-Executive Non-Independent Director via postal ballot. The ordinary resolution passed with 97.07% of votes in favour.

Gland Pharma Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹18,336 Mn (+23% YoY), PAT ₹2,908 Mn (+58%), adj. EBITDA margin 27%. US CDMO and launches lead; India and RoW weak.

Gland Pharma Results Update

Gland Pharma reported Q2FY27 revenue of Rs. 18,336 Mn, up 23% YoY, and PAT of Rs. 2,908 Mn, up 58% YoY. The press release accompanies its quarterly financial results filing.

Gland Pharma Q2 FY27 Results: Net Profit ₹290.8 Cr, Up 58.3% YoY

Gland Pharma Ltd reported revenue from operations of ₹1,834 Cr (+23.3% YoY) and net profit of ₹290.8 Cr (+58.3% YoY) for Q2 FY27.

Key figure

Net profit ₹290.8 Cr · +58.3% YoY